Filter
25
Filtered Results: 25
Text search:
A.
Colson
Featured
Recommendations
1
New Publications
2
Language
Document type
No document type
11
Studies & Reports
8
Guidelines
5
Manuals
1
Countries / Regions
Western and Central Europe
4
Russia
2
Congo, Democratic Republic of
1
USA
1
Uganda
1
South Sudan
1
Germany
1
Tanzania
1
Namibia
1
Brazil
1
Ecuador
1
Angola
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
9
Capacity Building
1
Clinical Guidelines
1
Toolboxes
COVID-19
8
Mental Health
5
TB
3
Disability
2
NTDs
2
Rapid Response
1
Refugee
1
Zika
1
HIV
1
Planetary Health
1
NCDs
1
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in An...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in v...
8 février 2018
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Many groups in sub-Saharan Africa have historically linked persons with disabilities with witchcraft as a component of a wider link between accusations of witchcraft and socially marginalized popula...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
7 February 2019
7 de febrero de 2019
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
ECDC Technical Report, Fourth Update 3 July 2020
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Острая респираторная вирусная инфекция (ОРВИ) – острое
инфекционное заболевание респираторного тракта, проявляющееся
воспалением верхних дыхательных путей, в б...
